## Consolidated Statement of Equity

**Year Ended**

|  | Sep 28, 2019 | Sep 29, 2018 | Sep 30, 2017 |
| --- | --- | --- | --- |
| **      Increase (Decrease) in Stockholders' Equity [Roll Forward]** |  |  |  |
|         Total Stockholders' Equity - Beginning balance | 107,147 | 134,047 | 128,249 |
| *          Total AOCI* | (584) | (3,454) | (150) |
| *          Retained earnings* | 45,898 | 70,400 | 98,330 |
| *          Common stock and additional paid-in capital* | 45,174 | 40,201 | 35,867 |
| *          Cumulative Foreign Currency Translation* | (1,463) | (1,055) | (354) |
| *          Unrealized Gains/Losses on Derivative Instruments* | 172 | 810 | (124) |
| *          Unrealized Gains/Losses on Marketable Securities* | 707 | (3,209) | 328 |
|         Common stock issued - Beginning balance |  |  |  |
| *          Common stock and additional paid-in capital - Ending balance* | 781 | 669 | 555 |
|         Common stock withheld related to net share settlement of equity awards - Beginning balance |  |  |  |
| *          Retained earnings* | 1,029 | 948 | 581 |
| *          Common stock and additional paid-in capital - Ending balance* | 2,002 | 1,778 | 1,468 |
|         Share-based compensation - Beginning balance |  |  |  |
| *          Common stock and additional paid-in capital - Ending balance* | 6,194 | 5,443 | 4,909 |
|         Tax benefit from equity awards, including transfer pricing adjustments - Beginning balance |  |  | 620 |
| *          Common stock and additional paid-in capital - Ending balance* |  |  | 620 |
|         Net Income - Beginning balance | 55,256 | 59,531 | 48,351 |
| *          Retained earnings - Ending balance* | 55,256 | 59,531 | 48,351 |
|         Dividends and dividend equivalents declared - Beginning balance |  |  |  |
| *          Retained earnings - Ending balance* | 14,129 | 13,735 | 12,803 |
|         Common stock repurchased - Beginning balance | 67,100 |  |  |
| *          Retained earnings - Ending balance* | 67,101 | 73,056 | 33,001 |
|         Cumulative effects of changes in accounting principles - Beginning balance |  |  |  |
| *          Retained earnings* |  |  |  |
| *          Total AOCI* |  |  |  |
| *          Accounting Standards Update 2016-16 - Retained earnings* |  |  |  |
| *          Accounting Standards Update 2016-01 - Unrealized Gains/Losses on Derivative Instruments* |  |  |  |
| *          Accounting Standards Update 2016-01 - Cumulative Foreign Currency Translation* |  |  |  |
| *          Accounting Standards Update 2016-01 - Total AOCI* |  |  |  |
| *          Accounting Standards Update 2016-01 - Unrealized Gains/Losses on Marketable Securities - Ending balance* |  |  |  |
|         Other comprehensive income/(loss) - Beginning balance | 2,781 | (3,026) | (784) |
| *          Total AOCI* | 2,781 | (3,026) | (784) |
| *          Unrealized Gains/Losses on Derivative Instruments* | (638) | 905 |  |
| *          Unrealized Gains/Losses on Marketable Securities* | 3,827 | (3,406) |  |
| *          Cumulative Foreign Currency Translation - Ending balance* | (408) | (525) |  |
|         Total Stockholders' Equity | 90,488 | 107,147 | 134,047 |
| *          Total AOCI* | (584) | (3,454) | (150) |
| *          Retained earnings* | 45,898 | 70,400 | 98,330 |
| *          Common stock and additional paid-in capital* | 45,174 | 40,201 | 35,867 |
| *          Cumulative Foreign Currency Translation* | (1,463) | (1,055) | (354) |
| *          Unrealized Gains/Losses on Derivative Instruments* | 172 | 810 | (124) |
| *          Unrealized Gains/Losses on Marketable Securities - Ending balance* | 707 | (3,209) | 328 |
|       Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU) | 3.00 | 2.72 | 2.40 |